150 related articles for article (PubMed ID: 33896822)
1. PMEPA1 facilitates non-small cell lung cancer progression via activating the JNK signaling pathway.
Tan B; Chen Y; Xia L; Yu X; Peng Y; Zhang X; Yang Z
Cancer Biomark; 2021; 31(3):203-210. PubMed ID: 33896822
[TBL] [Abstract][Full Text] [Related]
2. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
3. PMEPA1 Stimulates the Proliferation, Colony Formation of Pancreatic Cancer Cells via the MAPK Signaling Pathway.
Song M; Zhou B; Li B; Tian L
Am J Med Sci; 2021 Sep; 362(3):291-296. PubMed ID: 33857498
[TBL] [Abstract][Full Text] [Related]
4. LncRNA GAS5 modulates the progression of non-small cell lung cancer through repressing miR-221-3p and up-regulating IRF2.
Ma J; Miao H; Zhang H; Ren J; Qu S; Da J; Xu F; Zhao H
Diagn Pathol; 2021 May; 16(1):46. PubMed ID: 34022918
[TBL] [Abstract][Full Text] [Related]
5. Rab11-FIP2 suppressed tumor growth via regulation of PGK1 ubiquitination in non-small cell lung cancer.
Dong W; Li H; Wu X
Biochem Biophys Res Commun; 2019 Jan; 508(1):60-65. PubMed ID: 30471866
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
7. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
Hou G; Lu Z; Bi Y; Deng J; Yang X
Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
9. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
[TBL] [Abstract][Full Text] [Related]
10. LINC00958 Accelerates Cell Proliferation and Migration in Non-Small Cell Lung Cancer Through JNK/c-JUN Signaling.
Luo Z; Han Z; Shou F; Li Y; Chen Y
Hum Gene Ther Methods; 2019 Dec; 30(6):226-234. PubMed ID: 31855084
[TBL] [Abstract][Full Text] [Related]
11. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
13. ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9 axis.
Sun J; Hu JR; Liu CF; Li Y; Wang W; Fu R; Guo M; Wang HL; Pang M
BMC Cancer; 2023 Nov; 23(1):1108. PubMed ID: 37964204
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of m
Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J
Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555
[TBL] [Abstract][Full Text] [Related]
15. The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases.
Liang Y; Lei Y; Du M; Liang M; Liu Z; Li X; Gao Y
J Cell Mol Med; 2021 Jul; 25(14):7039-7051. PubMed ID: 34117717
[TBL] [Abstract][Full Text] [Related]
16. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
[TBL] [Abstract][Full Text] [Related]
17. TRB3 interacts with ERK and JNK and contributes to the proliferation, apoptosis, and migration of lung adenocarcinoma cells.
Cao X; Fang X; Malik WS; He Y; Li X; Xie M; Sun W; Xu Y; Liu X
J Cell Physiol; 2020 Jan; 235(1):538-547. PubMed ID: 31256425
[TBL] [Abstract][Full Text] [Related]
18. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
19. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration.
Huang Z; Sun Z; Zhang X; Niu K; Wang Y; Zheng J; Li H; Liu Y
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30745454
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]